Completed Transactions

Completed Transactions > Manufacturing > R&S Drugs Inc. Acquired By Private Investor

R&S Drugs Inc. Acquired By Private Investor

R&S Drugs


Jan 2017



Generational Capital Markets, Inc., Member FINRA/SIPC, announced the sale of its client, R&S Drugs Inc. of Duncan, Oklahoma, to a private investor. The acquisition closed January 6, 2017. Details were not disclosed.

Founded in 1945, R&S Drugs Inc. operates three community pharmacies in Duncan, which has a population of about 23,000. Combined, the three pharmacies fill approximately 250,000 prescriptions annually.

Majority owner Joe Pierce, a beloved fixture in Duncan, was passionate about finding a buyer who would continue to serve the patients of Duncan with the same care and attention he has provided for the last several decades.

Fortunately the buyer, a pharmacist with a background in pharmacy ownership and management, shares Pierce’s commitment to superior service to the community.

Generational Capital Markets Managing Directors Tom Staszak and Chris Gain successfully closed the deal.

“Although R&S Drugs generated interest from several other potential acquirers, Joe Pierce was focused on maintaining local ownership of the company,” said Staszak. “Selling the company to a person that already had a minority ownership position in R&S Drugs assured the existing commitment to outstanding personal service and local involvement will continue.”

You read more about the deal here.

Sell smart

Download our FREE exit planning whitepaper, detailing everything you need to know before you make any big decisions about selling. Leave your name and email address to have it sent directly to your inbox.

Exit planning basics: what you need to know before you start

Exit planning Basics: What your need to know before you start

Your whitepaper is ready, to download it please click the button below.